Improving the Tracking and Removal of Retrievable Inferior Vena Cava Filters

ABSTRACT

Therapeutic and prophylactic inferior vena cava (IVC) filters should be placed based on currently accepted indications to prevent a fatal pulmonary embolism (PE). The protective effect of filters is offset by the potential for lower extremity deep venous thrombosis (DVT), caval thrombosis, and possible otherwise unnecessary life-long anticoagulation (AC). The duration of treatment for most DVTs or PEs is 3 to 6 months of AC/filter. Filters should be retrieved when duration of treatment for a DVT/PE has been met, the risk of a PE is no longer high, and/or there is no longer a contraindication to AC. An effective system that leads to improving the retrieval rate of filters must include education of the patient, a tracking system to minimize patient lost to follow-up, and dedicated personnel to oversee the process. If these goals are accomplished, interventionalists can help decrease the incidence of a fatal PE during the high-risk period, and also decrease the risk of a DVT or the use of otherwise unnecessary life-long AC in subsequent years. Currently, there is much room for improvement in the frequency that IVCF patients are systematically followed and filters are retrieved. The principles discussed in this report will be helpful in this process.

Retrievable inferior vena cava filters - tracking inferior vena cava filter patients - improving retrieval of inferior vena cava filters

REFERENCES

• 1 Shackford S R, Cook A, Rogers F B, Littenberg B, Osler T. The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank.  J Trauma. 2007;  63 (4) 764-769
• 2 Aryafar H, Kinney T B. Optional inferior vena cava filters in the trauma patient.  Semin Intervent Radiol. 2010;  27 (1) 68-80
• 3 Rogers F B, Cipolle M D, Velmahos G, Rozycki G, Luchette F A. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group.  J Trauma. 2002;  53 (1) 142-164
• 4 Knudson M M, Collins J A, Goodman S B, McCrory D W. Thromboembolism following multiple trauma.  J Trauma. 1992;  32 (1) 2-11
• 5 Geerts W H, Code K I, Jay R M, Chen E, Szalai J P. A prospective study of venous thromboembolism after major trauma.  N Engl J Med. 1994;  331 (24) 1601-1606
• 6 Decousus H, Leizorovicz A, Parent F et al.. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.  N Engl J Med. 1998;  338 (7) 409-415
• 7 PREPIC Study Group . Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.  Circulation. 2005;  112 (3) 416-422
• 8 Brender E. Use of emboli-blocking filters increases, but rigorous data are lacking.  JAMA. 2006;  295 (9) 989-990
• 9 Levine M N, Raskob G, Beyth R J, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 (3, Suppl) 287S-310S
• 10 Ray Jr C E, Prochazka A. The need for anticoagulation following inferior vena cava filter placement: systematic review.  Cardiovasc Intervent Radiol. 2008;  31 (2) 316-324
• 11 Ray Jr C E, Mitchell E, Zipser S, Kao E Y, Brown C F, Moneta G L. Outcomes with retrievable inferior vena cava filters: a multicenter study.  J Vasc Interv Radiol. 2006;  17 (10) 1595-1604
• 12 Binkert C A, Drooz A T, Caridi J G et al.. Technical Success and safety of Rerieval of the G2 Filter in a prospective, Multicenter Study.  J Vasc Interv Radiol. 2009;  20 1595-1604
• 13 Johnson M S, Nemcek Jr A A, Benenati J F et al.. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study.  J Vasc Interv Radiol. 2010;  21 (8) 1173-1184
• 14 Kaufman J A, Kinney T B, Streiff M B et al.. Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference. 2006 17: 449-459
• 15 Removing Retrievable Inferior Vena Cava Filters .Initial Communication. FDA Communication dated August 9, 2010. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm 9/21/2010 Accessed February 16, 2011
• 16 SIR President James F. Benenati, MD, FSIR .Message from SIR President: Society of Interventional Radiology Responds to FDA Blood Clot Device (IVC Filter) Advisory. Available at: http://www.medpedia.com/news_analysis/356-Paul-J-Dorio-MD/entries/42409-IVC-Filters—Society-of-Interventional-Radiology-Advisory Accessed February 16, 2011
• 17 Kearon C, Kahn S R, Agnelli G, Goldhaber S, Raskob G E, Comerota A J. American College of Chest Physicians . Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133 (6, Suppl) 454S-545S
• 18 Schmelzer T M, Christmas A B, Taylor D A, Heniford B T, Sing R F. Vena cava filter retrieval in therapeutically anticoagulated patients.  Am J Surg. 2008;  196 (6) 944-946 discussion 946-947
• 19 Hoppe H, Kaufman J A, Barton R E et al.. Safety of inferior vena cava filter retrieval in anticoagulated patients.  Chest. 2007;  132 (1) 31-36
• 20 O'Keeffe T, Thekkumel T J, Friese S, Shafi S, Josephs S C. A policy of dedicated follow-up improves the rate of removal of retrievable inferior vena cava filters in trauma patients.  Am Surg. 2011;  In press